Real-world performance and safety of Halova® ovules in reducing the vaginal symptoms associated with vulvovaginal atrophy and postmenopausal sexual dysfunction
View ORCID ProfileDominic-Gabriel Iliescu, View ORCID ProfileRamona Petrita, Cristina Teodorescu, View ORCID ProfileRaluca Alexandra Olaru, View ORCID ProfileAndreea Anda Alexa, View ORCID ProfileIzabella Petre
doi: https://doi.org/10.1101/2023.05.17.23290093
Dominic-Gabriel Iliescu
aDiscipline of Obstetrics and Gynecology VIII, University of Medicine and Pharmacy Craiova, 2 Petru Rares Street, 200349 Craiova, Romania
b2nd Clinic of Obstetrics and Gynecology, Emergency County University Hospital Craiova, 1 Tabaci Street, 200642 Craiova, Romania,
Ramona Petrita
cBiometrics Unit, MDX Research, 1-3 Vasile Loichita Street, 300633 Timisoara, Romania
Cristina Teodorescu
dDiscipline of Obstetrics and Gynecology, “Nicolae Malaxa” Clinical Hospital, 12 Soseaua Vergului, 022441 Bucharest, Romania
Raluca Alexandra Olaru
eDepartment of Obstetrics and Gynecology III, Institutul National pentru Sanatatea Mamei si Copilului Alessandrescu Rusescu, Clinic of Obstetrics and Gynecology „Polizu”, 38-52 Gheorghe Polizu Street, District 1, 011061 Bucharest, Romania
fDiscipline of Obstetrics, Gynecology and Neonatology Spitalul Clinic Polizu “Carol Davila" University of Medicine and Pharmacy Bucharest, 8 Eroii Sanitari Boulevard, District 5, 050471 Bucharest, Romania
Andreea Anda Alexa
gDiscipline of Biochemistry IV, University of Medicine and Pharmacy Victor Babes, 2 Piata Eftimie Murgu, Timisoara, Romania
Izabella Petre
hDiscipline of Obstetrics and Gynecology III, University of Medicine and Pharmacy Victor Babes, 2 Piata Eftimie Murgu, Timisoara, Romania
i2nd Clinic of Obstetrics and Gynecology, Emergency County Clinic Hospital, 156 Liviu Rebreanu, 300723, Timisoara, Romania
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted July 21, 2023.
Real-world performance and safety of Halova® ovules in reducing the vaginal symptoms associated with vulvovaginal atrophy and postmenopausal sexual dysfunction
Dominic-Gabriel Iliescu, Ramona Petrita, Cristina Teodorescu, Raluca Alexandra Olaru, Andreea Anda Alexa, Izabella Petre
medRxiv 2023.05.17.23290093; doi: https://doi.org/10.1101/2023.05.17.23290093
Real-world performance and safety of Halova® ovules in reducing the vaginal symptoms associated with vulvovaginal atrophy and postmenopausal sexual dysfunction
Dominic-Gabriel Iliescu, Ramona Petrita, Cristina Teodorescu, Raluca Alexandra Olaru, Andreea Anda Alexa, Izabella Petre
medRxiv 2023.05.17.23290093; doi: https://doi.org/10.1101/2023.05.17.23290093
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2948)
- Dermatology (249)
- Emergency Medicine (440)
- Epidemiology (12754)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4588)
- Geriatric Medicine (419)
- Health Economics (729)
- Health Informatics (2918)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (426)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4364)
- Nursing (236)
- Nutrition (640)
- Oncology (2273)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1197)
- Primary Care Research (496)
- Public and Global Health (6947)
- Radiology and Imaging (1529)
- Respiratory Medicine (915)
- Rheumatology (438)
- Sports Medicine (385)
- Surgery (489)
- Toxicology (60)
- Transplantation (212)
- Urology (181)